Scilex Holding Company Announces Change in Record Date for Preferred Stock Dividend
PALO ALTO, Calif., March 10, 2025 – Scilex Holding Company (Nasdaq: SCLX), a trailblazing organization dedicated to acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain, as well as neurodegenerative and cardiometabolic diseases, has recently made an important announcement. The Company’s Board of Directors has approved the change of the previously announced record date for its dividend of Scilex preferred stock (the “Dividend”) from January 28, 2025, to a new record date.
New Record Date for Scilex Preferred Stock Dividend
The new record date for the Dividend is yet to be determined and will be announced by Scilex in due course. The Company encourages its stockholders and other eligible securityholders to keep their contact information up-to-date to ensure they receive any communication related to the Dividend, including the new record date and payment instructions.
Impact on Scilex Stockholders
The change in record date for the Dividend may have implications for Scilex stockholders. Those who hold Scilex shares before the new record date will be entitled to receive the Dividend, while those who purchase shares after this date will not be eligible. The exact impact on individual investors will depend on their purchase and holding periods. It is essential for stockholders to monitor their holdings closely and stay informed about any updates from Scilex regarding the Dividend.
Global Implications
The decision by Scilex to change the record date for its preferred stock Dividend may have broader implications for the financial markets and the biotech industry. This event could potentially influence investor sentiment towards Scilex and other companies in the sector, as well as impact market trends related to dividend policies and share buybacks.
Stay Informed
As Scilex continues to innovate and expand its product offerings, it is crucial for investors and industry observers to stay informed about the Company’s developments. Keeping up-to-date with Scilex’s announcements, financial reports, and industry trends can help investors make informed decisions and stay ahead of market movements. To learn more about Scilex and its mission, visit the Company’s website at www.scilex.com.
Conclusion
Scilex Holding Company’s recent announcement regarding the change in record date for its preferred stock Dividend has important implications for the Company’s stockholders and the broader financial markets. By staying informed and closely monitoring their holdings, investors can make the most of this situation and capitalize on the opportunities that may arise. As Scilex continues to push the boundaries of non-opioid pain management and expand into new therapeutic areas, it is an exciting time for the Company and the industry as a whole.
- Scilex Holding Company changes record date for preferred stock Dividend.
- New record date has yet to be determined.
- Scilex stockholders with shares before the new record date are entitled to receive the Dividend.
- Change may impact investor sentiment and market trends.
- Stay informed about Scilex and the biotech industry for the latest developments.
